login
  Password reminder
Interventional News
Contact the editor Visit Interventional News Twitter feed Visit Interventional News Facebook page
 

Hansen Medical showcases Magellan robotic system and NorthStar catheter at MEET congress in Italy


Wednesday, 07 Dec 2011 15:31
Magellan robotic system
Magellan robotic system


Hansen Medical showcased its Magellan robotic system at the Multidisciplinary European Endovascular Therapy (MEET) Congress, Rome, Italy (1–3 December 2011). 


The company also exhibited its NorthStar robotic catheter, designed to work with the Magellan robotic system. The NorthStar catheter is designed to simplify and enhance catheter navigation and therapeutic intervention in the peripheral vasculature. The Magellan robotic system and NorthStar robotic catheter are CE-marked and available for sale in Europe. They are 510(k) pending and not available for sale in the United States.


“We are excited to showcase our Magellan robotic system and NorthStar robotic catheter at this foremost exhibition on endovascular therapy, and this is an important event in the initial commercial launch of our new system platform,” said Bruce Barclay, president and CEO of Hansen Medical. “Based on the initial clinical and pre-clinical work and feedback from a number of leading clinicians worldwide, these products have the potential to optimise the way physicians navigate the vasculature. The CE marked system and catheter give physicians maximum flexibility and control through independent distal tip control of a catheter and a sheath as well as through robotic manipulation of a standard guidewire from a centralised, remote workstation. Moreover, this proprietary technology has the ability to provide physicians important clinical benefits by allowing precise and predictable catheter navigation of peripheral vessels.”


The Magellan robotic system and NorthStar robotic catheter are intended to be used to facilitate navigation to anatomical targets in the peripheral vasculature and subsequently provide a conduit for manual placement of therapeutic devices.


Last year, the company announced the completion of its first-in-man study in Europe during which 20 endovascular procedures were performed with an earlier version of the Magellan robotic system, demonstrating its potential to allow physicians to treat peripheral vascular disease, while lessening radiation exposure.




Add New Comment

Most popular


First patient enrolled in US study of Novate’s Sentry IVC filter
Monday, 22 Sep 2014
Novate Medical has announced that Souheil Saddekni, professor of Vascular and Interventional Radiology at the University of Alabama, Birmingham, USA, has enrolled the first patient in the SENTRY IDE ... First patient enrolled in US study of Novate’s Sentry IVC filter

First drug-eluting balloon approved in USA
Friday, 10 Oct 2014
The FDA has approved the Lutonix drug-eluting balloon for the management of peripheral artery disease. This is the first time that the agency has approved such a device for this indication in the USA. First drug-eluting balloon approved in USA

CIRSE 2014 audience needs more evidence before they support drug-elution in the superficial femoral artery
Friday, 26 Sep 2014
The audience in the CIRSE 2014 “Controversies in superficial femoral artery treatment” session failed to endorse two motions pertaining to drug-elution in this anatomical segment in the annual ... CIRSE 2014 audience needs more evidence before they support drug-elution in the superficial femoral artery

Features


What the trials have taught us about aggressive therapy of deep venous thrombosis
Thursday, 25 Sep 2014
Although current evidence in favour of catheter-directed thrombolysis for deep venous thrombosis may not be robust enough to allow for a shift in clinical practice, that may soon change with strict ... What the trials have taught us about aggressive therapy of deep venous thrombosis

The promise of chemical renal denervation
Friday, 05 Sep 2014
Tim A Fischell writes that chemical renal denervation using ethanol may have numerous advantages over energy-based “burning” technologies. The promise of chemical renal denervation

Profiles


José Ignacio Bilbao Jaureguízar
Wednesday, 08 Oct 2014
“No matter what their future orientation, interventional radiologists involved in interventional ... José Ignacio Bilbao Jaureguízar

Bien Soo Tan
Friday, 16 May 2014
Bien Soo Tan, senior consultant, Department of Diagnostic Radiology, Singapore General Hospital, S... Bien Soo Tan

Cardiac Rhythm News Vascular News Cardiovascular News Interventional News Spinal News NeuroNews
BIBA Medical BIBA MedTech Insights CX Symposium ilegx
 
Password Reminder

BIBA Medical, 526 Fulham Road, Fulham, London, SW6 5NR.
TEL: +44 (0)20 7736 8788 FAX: +44 (0)20 7736 8283 EMAIL: 
info@bibamedical.com
© BIBA Medical Ltd is a company registered in England and Wales with company number 2944429.
VAT registration number 730 6811 50.
Site Map | Terms and Conditions